Cargando…

Targeting cancer cachexia: Molecular mechanisms and clinical study

Cancer cachexia is a complex systemic catabolism syndrome characterized by muscle wasting. It affects multiple distant organs and their crosstalk with cancer constitute cancer cachexia environment. During the occurrence and progression of cancer cachexia, interactions of aberrant organs with cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yong‐Fei, An, Zi‐Yi, Lin, Dong‐Hai, Jin, Wei‐Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464063/
https://www.ncbi.nlm.nih.gov/pubmed/36105371
http://dx.doi.org/10.1002/mco2.164
_version_ 1784787503162589184
author Wang, Yong‐Fei
An, Zi‐Yi
Lin, Dong‐Hai
Jin, Wei‐Lin
author_facet Wang, Yong‐Fei
An, Zi‐Yi
Lin, Dong‐Hai
Jin, Wei‐Lin
author_sort Wang, Yong‐Fei
collection PubMed
description Cancer cachexia is a complex systemic catabolism syndrome characterized by muscle wasting. It affects multiple distant organs and their crosstalk with cancer constitute cancer cachexia environment. During the occurrence and progression of cancer cachexia, interactions of aberrant organs with cancer cells or other organs in a cancer cachexia environment initiate a cascade of stress reactions and destroy multiple organs including the liver, heart, pancreas, intestine, brain, bone, and spleen in metabolism, neural, and immune homeostasis. The role of involved organs turned from inhibiting tumor growth into promoting cancer cachexia in cancer progression. In this review, we depicted the complicated relationship of cancer cachexia with the metabolism, neural, and immune homeostasis imbalance in multiple organs in a cancer cachexia environment and summarized the treatment progress in recent years. And we discussed the molecular mechanism and clinical study of cancer cachexia from the perspective of multiple organs metabolic, neurological, and immunological abnormalities. Updated understanding of cancer cachexia might facilitate the exploration of biomarkers and novel therapeutic targets of cancer cachexia.
format Online
Article
Text
id pubmed-9464063
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94640632022-09-13 Targeting cancer cachexia: Molecular mechanisms and clinical study Wang, Yong‐Fei An, Zi‐Yi Lin, Dong‐Hai Jin, Wei‐Lin MedComm (2020) Reviews Cancer cachexia is a complex systemic catabolism syndrome characterized by muscle wasting. It affects multiple distant organs and their crosstalk with cancer constitute cancer cachexia environment. During the occurrence and progression of cancer cachexia, interactions of aberrant organs with cancer cells or other organs in a cancer cachexia environment initiate a cascade of stress reactions and destroy multiple organs including the liver, heart, pancreas, intestine, brain, bone, and spleen in metabolism, neural, and immune homeostasis. The role of involved organs turned from inhibiting tumor growth into promoting cancer cachexia in cancer progression. In this review, we depicted the complicated relationship of cancer cachexia with the metabolism, neural, and immune homeostasis imbalance in multiple organs in a cancer cachexia environment and summarized the treatment progress in recent years. And we discussed the molecular mechanism and clinical study of cancer cachexia from the perspective of multiple organs metabolic, neurological, and immunological abnormalities. Updated understanding of cancer cachexia might facilitate the exploration of biomarkers and novel therapeutic targets of cancer cachexia. John Wiley and Sons Inc. 2022-09-10 /pmc/articles/PMC9464063/ /pubmed/36105371 http://dx.doi.org/10.1002/mco2.164 Text en © 2022 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Wang, Yong‐Fei
An, Zi‐Yi
Lin, Dong‐Hai
Jin, Wei‐Lin
Targeting cancer cachexia: Molecular mechanisms and clinical study
title Targeting cancer cachexia: Molecular mechanisms and clinical study
title_full Targeting cancer cachexia: Molecular mechanisms and clinical study
title_fullStr Targeting cancer cachexia: Molecular mechanisms and clinical study
title_full_unstemmed Targeting cancer cachexia: Molecular mechanisms and clinical study
title_short Targeting cancer cachexia: Molecular mechanisms and clinical study
title_sort targeting cancer cachexia: molecular mechanisms and clinical study
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464063/
https://www.ncbi.nlm.nih.gov/pubmed/36105371
http://dx.doi.org/10.1002/mco2.164
work_keys_str_mv AT wangyongfei targetingcancercachexiamolecularmechanismsandclinicalstudy
AT anziyi targetingcancercachexiamolecularmechanismsandclinicalstudy
AT lindonghai targetingcancercachexiamolecularmechanismsandclinicalstudy
AT jinweilin targetingcancercachexiamolecularmechanismsandclinicalstudy